Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody.
Affiliation
CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, UK.Issue Date
1990-06
Metadata
Show full item recordAbstract
The expression of epidermal growth factor receptor (EGF-R) in 34 formalin fixed paraffin embedded specimens of malignant mesothelioma was examined using the F4 antibody. Eight samples of reactive pleura showed homogenous cytoplasmic staining with the antibody. EGF-R positive cells (greater than or equal to 5%) were found in 68% of the mesotheliomas examined. EGF-R positivity was more commonly seen in the epithelial histological subtype than in the sarcomatous or mixed subtypes. Patients with less than 5% of mesothelioma cells staining positive for EGF-R had a significantly shorter survival (median 299 days) compared with patients whose tumours had a greater number of cells positive for EGF-R (median 446 days) (P = 0.04). However, when the histological subgroup was also taken into consideration (epithelial type had a significantly longer survival than the sarcomatous or mixed) the survival difference in relation to EGF-R positivity was no longer significant (P = 0.08). EGF-R could not be used to distinguish between malignant and benign mesothelial tissue and was not an independent prognostic factor for survival.Citation
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody. 1990, 61 (6):924-6 Br J CancerJournal
British Journal of CancerPubMed ID
2372497Type
ArticleLanguage
enISSN
0007-0920Collections
Related articles
- Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.
- Authors: Ramael M, Segers K, Buysse C, Van den Bossche J, Van Marck E
- Issue date: 1991
- Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour.
- Authors: Law MR, Hodson ME, Heard BE
- Issue date: 1982 Nov
- Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.
- Authors: Churg A
- Issue date: 1985 May
- p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections.
- Authors: Mayall FG, Goddard H, Gibbs AR
- Issue date: 1992 Dec
- Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival.
- Authors: Dazzi H, Hasleton PS, Thatcher N, Barnes DM, Wilkes S, Swindell R, Lawson RA
- Issue date: 1989 May